Beneficial effects of modulated Electro- Hyperthermia during neoadjuvant treatment for locally advanced Rectal Cancer

2021-12-05T10:51:30+00:00December 5th, 2021|

Beneficial effects of modulated Electro- Hyperthermia during neoadjuvant treatment for locally advanced Rectal Cancer Survival analysis CONTACT US Summary This study investigates the effects of Electro-hyperthermia on patients with [...]

Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study

2021-12-05T10:39:30+00:00December 5th, 2021|

Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study Effect on survival CONTACT US Summary This study investigates the effects of Electro-hyperthermia on [...]

Vaccination with poly(IC:LC) and peptide-pulsed autologous Dendritic cells in Patients with Pancreatic Cancer

2021-12-05T10:20:39+00:00December 5th, 2021|

Vaccination with poly(IC:LC) and peptide-pulsed autologous Dendritic cells in Patients with Pancreatic Cancer CT scan. CONTACT US Summary This study investigates, DC-based immunotherapy, in conjunction with toll-like receptor (TLR)-3 [...]

Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients

2021-12-05T09:35:04+00:00December 5th, 2021|

Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients Increased blood pressure, or rhythm changes during mEHT treatments. CONTACT US [...]

Treatment outcome analysis of chemotherapy combined with modulated electro-hyperthermia compared with chemotherapy alone for recurrent cervical cancer, following irradiation

2021-11-30T10:07:16+00:00November 30th, 2021|

Treatment outcome analysis of chemotherapy combined with modulated electro-hyperthermia compared with chemotherapy alone for recurrent cervical cancer, following irradiation Treatment characteristics CONTACT US Summary A combinational [...]

A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin� 2

2021-12-05T07:14:34+00:00November 30th, 2021|

A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin 2 Overall survival rate CONTACT US Summary [...]

Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02)

2021-12-01T05:59:50+00:00November 30th, 2021|

Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02) Overall survival rate CONTACT US Summary The data aims to examine patients with platinum-sensitive ovarian [...]

Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial

2021-11-22T10:55:34+00:00November 19th, 2021|

Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial Change in expression CONTACT US Summary This study examines patients with Glioblastoma multiforme (GBM) [...]

Go to Top